Telehealth Anxiety Prescribing: What Psychiatrists Can Do in New York

If you’re a psychiatrist or PMHNP wondering whether you can manage anxiety patients remotely — including prescribing controlled substances like benzodiazepines — the short answer is yes, you can. But the details matter, especially when it comes to state regulations, federal telehealth rules, and reimbursement realities.

Here’s what you actually need to know about telehealth anxiety prescribing in 2026, cut through the noise.

The Current Federal Rules: Telehealth Prescribing Is Still Wide Open (For Now)

Let’s start with the big one: Can you prescribe controlled substances for anxiety via telehealth without seeing the patient in person first?

Yes — through at least December 2026.

The DEA and HHS extended COVID-era telehealth flexibilities through 2026, meaning you can initiate and manage Schedule II-V controlled substances (including benzodiazepines, stimulants for comorbid ADHD, etc.) entirely via video visit without a prior in-person exam. This extension affects over 7 million prescriptions annually and was designed to prevent a ‘telemedicine cliff’ where patients would suddenly lose access to care.

What this means for your practice:

• You can do a first-time video evaluation of a patient with panic disorder and prescribe alprazolam (Xanax) the same day
• Follow-up med management visits for anxiety can be 100% virtual
• No special DEA registration required beyond your standard DEA license (for now)

The catch: This is still a temporary extension. The DEA is expected to finalize permanent telehealth prescribing rules by late 2026, which may reinstate some exam requirements or introduce a special telemedicine registration. Stay alert for those changes, but for the remainder of 2026, you’re operating under the current flexible framework.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Prescribing Rules: Where It Gets Interesting

Federal rules allow telehealth prescribing, but state laws add their own layers. Here’s what matters in the major states:

California

Psychiatrists have full prescribing authority with no telehealth-specific restrictions. You can manage anxiety patients remotely and prescribe any medication you would in person.

For PMHNPs: California was historically restrictive (requiring physician-supervised standardized procedures), but AB 890 is changing that. As of January 2026, experienced NPs who qualify as ‘104 NPs’ can practice completely independently — opening their own practices, prescribing controlled substances, no physician oversight needed. This is a dramatic shift. If you’re a newer PMHNP still operating under the old rules, you’ll need physician protocols until you hit the experience thresholds.

California has strong telehealth parity laws (AB 744) ensuring private insurers pay the same for virtual visits as in-person.

Texas

Texas allows telehealth prescribing of anxiety medications with one major caveat: you cannot use telemedicine to treat chronic pain with controlled substances. Anxiety treatment doesn’t fall under this prohibition, so benzodiazepines and other anxiolytics are fair game via telehealth.

For PMHNPs: Texas is restrictive. You must have a Prescriptive Authority Agreement with a physician, and you cannot prescribe Schedule II controlled substances (like stimulants) outside hospital-based settings. For typical anxiety meds (SSRIs, SNRIs, benzos which are Schedule IV), you can prescribe if your delegating physician authorizes it. But you’ll never practice independently in Texas without a law change.

Texas doesn’t mandate telehealth payment parity for private insurance, but most major insurers pay equivalently anyway. The state participates in the Interstate Medical Licensure Compact (IMLC), making multi-state licensure easier for psychiatrists.

Florida

Florida explicitly permits telehealth prescribing of Schedule II drugs for psychiatric disorders — a carve-out that recognizes mental health treatment. Benzodiazepines (Schedule IV) have no restrictions for telehealth.

Key rule: All prescribers must check Florida’s PDMP (E-FORCSE) before writing controlled substance scripts.

For PMHNPs: Florida requires a written physician protocol for all NP practice. There’s a 7-day supply limit on controlled substances for NPs unless you’re a psychiatric NP treating a mental health condition — then you can prescribe normal quantities. You’ll need physician collaboration, but you can manage anxiety med-management fairly autonomously day-to-day within your protocol.

Florida offers an Out-of-State Telehealth Provider Registration for providers licensed elsewhere, but registrants cannot prescribe controlled substances remotely. You need a full Florida license for that.

New York

New York is now a full practice authority state for NPs. As of 2022, PMHNPs can practice completely independently with no physician agreement required. You can open your own practice, prescribe any anxiety medication, manage patients autonomously.

For psychiatrists, no special restrictions. Telehealth is integrated into standard practice.

Important: New York has one of the strictest PDMP mandates in the country — you must check the iSTOP database for every single controlled substance prescription with very few exceptions. Build this into your workflow.

Pennsylvania

Pennsylvania is a restricted state for NPs. PMHNPs must maintain a collaborative agreement with a physician to prescribe. The physician must review a percentage of your charts (100% of Schedule II prescriptions within 24 hours), which affects how independently you can manage anxiety patients who need stimulants or other Schedule II meds.

Psychiatrists practice independently. Pennsylvania doesn’t have a comprehensive telehealth statute, but telemedicine is widely practiced under board guidance and federal rules. Most insurers reimburse telepsychiatry at parity voluntarily.

Illinois

Illinois offers a pathway to full practice authority for NPs after 4,000 clinical hours + 250 CE hours. Once you achieve FPA status, you can practice independently, but there’s still a one-time physician sign-off required for prescribing Schedule II narcotics and benzodiazepines.

For anxiety treatment, this means: an experienced Illinois PMHNP with FPA can prescribe Xanax after getting that initial physician attestation. New PMHNPs operate under standard collaboration requirements.

Illinois has strong telehealth parity laws and Medicaid coverage for tele-mental health. PDMP checks required every 90 days for ongoing controlled substance prescriptions.

PMHNP vs MD Prescribing Authority: What’s Really Different?

The biggest question providers ask: What can a PMHNP do versus a psychiatrist when it comes to anxiety meds?

Psychiatrists (MD/DO):

• Unrestricted prescribing authority in all 50 states
• Can prescribe any anxiety medication independently (SSRIs, SNRIs, benzodiazepines, beta-blockers, off-label treatments)
• No supervision requirements ever
• Can practice across state lines via telehealth with appropriate licensure

PMHNPs:

• Prescribing authority varies by state based on Full Practice, Reduced Practice, or Restricted Practice categories
• In Full Practice states (NY, AZ, OR, WA, etc.): effectively equal to psychiatrists for anxiety treatment
• In Reduced/Restricted states (TX, PA, FL, IL for new grads, CA for some): require physician collaboration or supervision
• Some states restrict NP prescribing of Schedule II controlled substances more than physicians
• All states require PMHNPs to have DEA registration to prescribe controlled anxiolytics

Practical example: A patient with panic disorder needs alprazolam (Schedule IV benzodiazepine).

• New York PMHNP: Can prescribe independently after checking PDMP
• Texas PMHNP: Can prescribe if authorized in physician delegation agreement
• Pennsylvania PMHNP: Can prescribe, but physician must be available for consultation
• Any state psychiatrist: Can prescribe, period

For routine anxiety management with SSRIs/SNRIs (first-line treatment), PMHNPs and psychiatrists are functionally equivalent in most states. The gap widens with controlled substances and in states with restrictive collaboration laws.

Reimbursement Reality: What You’ll Actually Get Paid

Let’s talk money, because this affects whether telehealth anxiety treatment is financially viable.

Medicare Reimbursement (2026 rates):

• Initial psychiatric evaluation (90792): ~$202
• 15-minute med check follow-up (99213): ~$95
• 25-minute follow-up (99214): ~$136
• 30-minute therapy add-on (90833): ~$81

Medicare has extended telehealth payment parity — virtual visits pay the same as in-person through at least September 2025, and likely into 2026 based on recent legislation. This makes telepsychiatry financially equivalent to in-person care for Medicare patients.

One wrinkle: Medicare was supposed to require an in-person visit every 6 months for tele-mental health services, but enforcement has been delayed. Verify current policy, as this could affect pure-telehealth practices serving Medicare patients.

Medicaid Reimbursement:Roughly 50-60% of Medicare rates:

• Initial eval: ~$85
• Med check: $40-50

Lower per-visit pay, but higher volume can compensate. Most states now cover tele-mental health at parity with in-person and allow it from the patient’s home.

Private Insurance:Generally 100-150% of Medicare rates. Many states mandate telehealth payment parity (CA, IL, NY), meaning insurers must pay equally for virtual and in-person services. Even states without mandates (like TX) often see voluntary parity from major insurers.

PMHNP Reimbursement:Medicare pays NPs at 85% of physician rates when billing under their own NPI. For example, if a psychiatrist gets $100 for a med check, a PMHNP gets $85 for the same visit. Some private insurers also use this differential; others pay equal rates.

What this means for your bottom line:A psychiatrist doing 20 med checks/week at ~$100 average = $2,000/week in collections. An NP doing the same volume might see $1,700/week in collections from Medicare patients. The overhead is lower in telehealth (no office rent, often platform handles billing), which improves margins.

Many telepsychiatry platforms pay per visit (similar to these rates minus a service fee) or offer salaried positions with expected visit volume.

The Economics of Patient Acquisition: Why Platforms Make Sense

Here’s where marketing realities intersect with prescribing authority.

DIY Marketing Reality:If you decide to build your own telehealth practice and acquire patients yourself, here’s what you’re actually facing:

• SEO takes 6-12 months of consistent content creation and technical optimization before generating meaningful patient flow
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert. Realistic cost per booked patient: $200-400+
• Directory listings (Psychology Today, Zocdoc) charge monthly fees PLUS you compete with hundreds of other providers. Zocdoc charges $35-100+ per booking, and total monthly costs add up
• Total monthly marketing spend for a solo provider trying to generate 20+ new patients/month: $3,000-5,000 with uncertain results

When you factor in ALL costs — agency fees, ad testing, staff time to handle leads, no-show rates from cold leads, months of investment before results — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.

And that’s if you have the expertise, budget, and patience. Most providers don’t.

The Platform Alternative:Platforms like Klarity Health use a pay-per-appointment model. You pay a standard listing fee per new patient lead — only when a qualified patient actually books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad dollars.

Key value propositions:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule and only pay when you see patients
• Guaranteed ROI vs gambling on marketing channels

Frame it this way: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books. That’s a fixed cost-per-acquisition with zero risk.

For providers in states with restrictive collaboration requirements (Texas, Pennsylvania PMHNPs), platforms can also help arrange physician relationships or focus recruitment in states where you have more autonomy.

Controlled Substance Monitoring: Non-Negotiable Compliance

Every state requires PDMP checks before prescribing controlled anxiety medications. This is table stakes for telehealth prescribing:

State-by-State PDMP Requirements:

• California: CURES database check required
• Texas: Texas PMP Aware mandatory
• Florida: E-FORCSE must be queried
• New York: iSTOP required for every controlled prescription
• Pennsylvania: ABC-MAP check required
• Illinois: Illinois PMP check required (and every 90 days for ongoing treatment)

Most telehealth platforms integrate PDMP access into their EHR workflows, but verify this before starting. Missing a PDMP check isn’t just bad practice — it’s a license violation and can trigger DEA scrutiny.

What to Watch: Regulatory Changes Coming

DEA Permanent Rules (Expected Late 2026):The current telehealth prescribing flexibilities are temporary. The DEA is drafting permanent regulations that may include:

• Special telemedicine prescribing registration
• Reinstatement of some in-person exam requirements
• Additional guardrails for controlled substance prescribing

The extension through December 2026 gives regulators time to finalize rules ‘that balance patient access with safety and preventing misuse.’ Stay tuned.

State Scope of Practice Expansions:Several states have NP independence bills in progress. If you’re a PMHNP in a restricted state, this could change your practice landscape. Pennsylvania and Texas have seen repeated FPA bills introduced (though none have passed yet). California’s AB 890 implementation continues to roll out.

Medicare Telehealth Policy:The in-person visit requirement for Medicare tele-mental health has been delayed multiple times. Whether it becomes permanent or gets repealed will significantly affect telehealth psychiatry’s Medicare viability.

The Bottom Line for Providers

If you’re a psychiatrist:You can practice anxiety medication management via telehealth in any state where you’re licensed, with full prescribing authority including controlled substances. The economics are solid (Medicare pays well, private insurance follows), and platforms eliminate patient acquisition headaches. The main consideration is multi-state licensure if you want to maximize patient access.

If you’re a PMHNP:Your ability to prescribe anxiety meds independently depends entirely on your state. In Full Practice states (NY, AZ, OR, etc.), you’re on equal footing with psychiatrists. In restricted states, you’ll need physician collaboration — but platforms can often facilitate those relationships or focus on states where you have more autonomy. Reimbursement is slightly lower (85% of MD rates for Medicare), but volume and lower overhead can offset this.

The platform advantage:Whether MD or NP, joining a telehealth network like Klarity removes the patient acquisition gamble. Instead of spending thousands monthly on marketing with uncertain ROI, you pay only when qualified patients book — and you get pre-built telehealth infrastructure, credentialing support, and (for NPs in restricted states) potential collaboration arrangements.

The anxiety treatment market is massive and underserved. Psychiatrist shortages persist nationwide (Texas: 1 psychiatrist per 8,966 residents; Florida: 1 per 8,577). Telehealth is the most efficient way to meet this demand — but only if you understand the regulatory landscape and have a sustainable patient acquisition strategy.

Ready to explore how Klarity can help you build a telepsychiatry practice without the marketing headache? [Learn more about joining Klarity’s provider network →]

FAQ: Anxiety Medication Prescribing via Telehealth

Can psychiatrists prescribe benzodiazepines via telehealth without seeing a patient in person first?

Yes, through at least December 2026 under federal COVID-era telehealth flexibilities. The DEA and HHS extended these rules specifically to allow controlled substance prescribing (including Schedule IV benzodiazepines like Xanax, Ativan, Klonopin) via video visits without a prior in-person exam. You must still conduct an appropriate evaluation via telehealth and comply with state PDMP requirements.

What’s the difference between PMHNP and psychiatrist prescribing authority for anxiety meds?

Psychiatrists (MD/DO) can prescribe any anxiety medication independently in all states with no supervision requirements. PMHNPs’ authority varies by state:

• Full Practice states (NY, AZ, OR, WA): PMHNPs prescribe independently, equal to psychiatrists
• Reduced Practice states (IL, CA for some): Require physician collaboration, but experienced NPs can gain independence
• Restricted states (TX, PA, FL): Require ongoing physician supervision/delegation agreements

For controlled substances specifically, some states (Texas, Florida, Pennsylvania) have additional restrictions on NP prescribing of Schedule II drugs that don’t apply to physicians.

Do I need a separate DEA license for each state where I practice telehealth?

Yes. You need a DEA registration in each state where you’re prescribing controlled substances. Your DEA number is tied to a specific state license and practice location. Many telehealth providers maintain licenses and DEA registrations in multiple states to maximize patient access. The IMLC (Interstate Medical Licensure Compact) can streamline multi-state licensing for physicians.

What anxiety medications can I prescribe via telehealth?

All of them, assuming you’re licensed and have DEA authority in that state:

• First-line: SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine)
• Second-line: Buspirone, beta-blockers (propranolol), hydroxyzine
• Controlled substances: Benzodiazepines (alprazolam, lorazepam, clonazepam), gabapentin
• Off-label: Low-dose quetiapine, mirtazapine, others as clinically appropriate

State telehealth laws may restrict how you prescribe (e.g., Florida’s psychiatric disorder exemption for Schedule II), but the medication classes themselves are available.

How much does Medicare pay for anxiety medication management visits?

2026 Medicare rates:

• Initial psychiatric evaluation (90792): $202
• 15-minute med check (99213): $95
• 25-minute med check (99214): $136
• 30-minute therapy add-on (90833): $81

Telehealth visits currently pay the same as in-person through Medicare’s extended parity policies. PMHNPs are reimbursed at 85% of these rates when billing under their own NPI.

What states allow PMHNPs to prescribe anxiety medications independently?

As of 2026, roughly 25+ states allow Full Practice Authority for NPs. Key states:

• Yes, full independence: New York, Arizona, Oregon, Washington, Alaska, Hawaii, Maryland, Montana, New Mexico, Rhode Island, others
• Pathway to independence: California (AB 890 – experienced NPs as of 2026), Illinois (4,000 hours + FPA application)
• No independence: Texas, Florida, Pennsylvania, Georgia, South Carolina, others

Check the AANP’s state practice environment map for the most current list.

Do I have to check the state PDMP every time I prescribe a benzodiazepine?

Most states require PDMP checks before initiating a controlled substance and periodically thereafter (often every 90 days or at every visit). New York is the strictest — requiring a check for literally every controlled prescription. Check your specific state’s law, but best practice is to query the PDMP at:

• Initial prescription of any controlled anxiolytic
• Any dose increase or medication change
• Regular intervals (every 90 days minimum) for ongoing treatment

Most telehealth EHRs integrate PDMP access to streamline this.

Can I prescribe Xanax to a patient in another state via telehealth?

Only if you hold an active medical license in that patient’s state at the time of the visit, plus a DEA registration in that state. Telehealth doesn’t eliminate state licensing requirements — you must be licensed where the patient is physically located during the visit. Some states offer telehealth-specific license registrations, but these often prohibit controlled substance prescribing (e.g., Florida’s out-of-state telehealth registration).

What’s the best way to acquire new patients for a telehealth anxiety practice without spending thousands on marketing?

Join a telehealth platform with built-in patient flow. DIY marketing (SEO, Google Ads, directories) realistically costs $200-500+ per acquired patient when you factor in all expenses and time investment, and takes 6-12 months to generate meaningful volume. Platforms like Klarity use a pay-per-appointment model where you pay only when a qualified patient books — no upfront marketing spend, no monthly fees, no patient acquisition risk. You get pre-qualified patients matched to your specialty and control your own schedule.

Top 5 Citations

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov)
   Official government source confirming federal telehealth prescribing policy extension through December 2026
   https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov)
   State law text defining PMHNP scope and telehealth prescribing rules including psychiatric disorder exemption
   https://www.flsenate.gov/laws/statutes/2024/464.012
   https://www.flsenate.gov/laws/statutes/2022/456.47

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov)
   State regulatory guidance on new NP independent practice categories (103 NP and 104 NP pathways)
   https://rn.ca.gov/practice/ab890.shtml

4. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com)
   Medicare and Medicaid reimbursement data for psychiatric billing codes based on CMS fee schedules
   https://therathink.com/insurance-reimbursement-rates-for-psychiatrists/

5. Texas Medical Board FAQ – NP Prescribing of Schedule II Drugs (tmb.state.tx.us)
   State board guidance on physician delegation limits for controlled substances including hospital-only restrictions
   https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs